Background: Although many patients who undergo reduction mammaplasty are obese, reports on whether obesity is a risk factor for postoperative complications have been conflicting. Objectives: This systematic literature review and meta-analysis aimed to evaluate the relationship between obesity and surgical complications after reduction mammaplasty. Methods: The PubMed, Medline, and Embase databases were searched between 1998 and 2016 using the MeSH terms and keywords "reduction mammoplasty (mammaplasty)," "breast reduction," "obesity," "body weight," "body mass index," and "risk factor." Results: Among 26 studies that reported surgical complication risk and patient body weight, 11 concluded that obesity is not a risk factor and 15 reported that high body mass index increases surgical risk. On comparing obese and non-obese patients, we found that obese patients had a higher relative risk of surgical complications (1.38, 95% confidence interval 1.13-1.69), particularly skin and fat necrosis (2.01, 95% confidence interval 1.54-2.63). The pooled risk further increased with an increase in body mass index, and it was 1.71 for body mass index >35 kg/m 2 and 2.05 for body mass index >40 kg/m 2 . Conclusions: Our meta-analysis indicated that the risk of surgical complications and tissue necrosis after reduction mammaplasty is higher in obese patients than in non-obese patients and that the risk gradually increases with an increase in the severity of obesity. The findings of this study could form a basis for preoperative patient education, surgical method selection, and determination of the extent of postoperative care.
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For macromastia patients, reduction mammaplasty is a very important functional and aesthetic procedure to improve function and relieve painful symptoms associated with large breasts, as well as to obtain better cosmetic results, [1] [2] [3] and thus, it is associated with a significant increase in the quality of life. Most clinicians regard this surgery as a treatment that is not purely limited to aesthetic purposes. [4] [5] [6] Considering the disease characteristics of macromastia or gigantomastia, it is understandable that many patients undergoing reduction mammaplasty are obese. 7 Numerous studies have investigated whether obesity acts as a risk factor for surgical complications after reduction mammaplasty; however, the findings have been inconsistent across studies. The difference in opinions among the studies can alter the selection of patients and lead to confusion with regard to the decision of whether the surgery should be postponed until the patient successfully loses weight.
Compared to well-known risk factors, such as active smoking and diabetes, [8] [9] [10] which have been shown to interfere with wound healing in both experimental and observational studies, [11] [12] [13] [14] overweight and obesity are not definitively regarded as factors that increase the surgical risk. As the majority of previously performed comparative analyses and single-center studies had the limitations of a small patient pool and surgeon-specific bias, we believed that a meta-analysis consisting of a large study population and various study results on this controversial topic would provide objective and unbiased findings that are not influenced by any personal opinions.
Hence, we conducted a comprehensive, systematic literature review of previously published studies and investigated the risk of surgical complications by performing a meta-analysis in order to achieve objective conclusions. The main aim of this systematic review and meta-analysis was to provide information to clarify the relationship between obesity and surgical complications after reduction mammaplasty.
METHODS
Between February and June 2015, the two authors (Y.J.M. and C.Y.H.) independently conducted literature searches and reviewed each other's results. If disagreements arose, we discussed the results with three colleagues from our department who are board-certified plastic surgeons and have experience in breast surgery, and the most common opinion was chosen. The bibliographical databases of PubMed, Medline, and Embase were searched for studies published between 1998 and 2016. The MeSH terms and keywords "reduction mammoplasty (mammaplasty)," "breast reduction," "obesity," "body weight," "body mass index," and "risk factor" were combined and utilized according to the Cochrane archive guidelines. 15, 16 In addition, 91 articles were identified by manual searching based on the references of the articles identified through the search using keywords. These additional articles had been published in journals that were not present in the PubMed, Medline, or Embase databases.
Study Selection
The inclusion criteria were as follows: (1) outcome analysis of reduction mammaplasty; (2) a minimum follow-up period of 90 days; (3) reporting of data on body mass index (BMI) or body weight of the patients; (4) a minimum study population of 30 patients; and (5) clear statements regarding the types of complications. Articles that met the following criteria were excluded: (1) animal or in vivo studies; (2) no clear reporting of BMI or body weight of the patients; (3) missing data on surgical complications; (4) data from oncological breast-conserving surgery patients; and (5) text not written in English.
Following the PICOT format, the population of our research was patients with macromastia, the intervention was reduction mammaplasty in obese patients, the comparative intervention was reduction mammaplasty in normal weight individuals, the outcome was relative risk (RR) of various complications, and the time horizon was a minimum follow-up of 90 days.
Among the studies included in the systematic review, those that reported surgical complication incidence and performed a subgroup analysis of preoperative patient BMI were eligible for inclusion in the meta-analysis. RR was investigated according to the designation of class I (BMI > 30 kg/m 2 ), class II (BMI > 35 kg/m 2 ), and class III (BMI > 40 kg/m 2 ) obesity based on the classification of the World Health Organization. Articles only reporting the RR or odds ratio with regard to BMI and complication incidence were excluded from the meta-analysis.
The types of complications considered in this review were superficial and deep surgical site infections, hematoma or hemorrhage, seroma, delayed wound healing, and skin flap or fat necrosis occurring during the early postoperative period. Reports of major medical complications, such as pulmonary or cardiac problems, thromboembolism, and death, were not found, and subjective symptoms and aesthetic dissatisfaction were excluded to overcome issues of data uniformity and to eliminate bias.
Quality Assessment
Quality was assessed in all studies included in our metaanalysis based on the star system of the Newcastle-Ottawa Scale (NOS) for meta-analysis of nonrandomized studies. 17 The NOS consists of the following three main categories for assessing the methodological quality of cohort studies: selection of the cohort, comparability, and outcome. One or two "stars" are given at each checkpoint, for a maximum of nine stars in total. Studies with six or more stars were graded as high-quality studies, those with three to six stars were graded as moderate quality studies, and those with less than three stars were graded as low-quality studies.
Data Extraction
Based on the guidelines of the Cochrane archive 16 and the Meta-analysis of Observational Studies in Epidemiology Group, 18 data on the first author, publication year, title, institutional information, study characteristics, follow-up periods, complication definition, obesity definition and measurements, confounders, and complication incidences were independently recorded by using a standardized form.
Statistical Analysis
The meta-analysis was conducted by using R (version 3.2.3, R Foundation for Statistical Computing, Vienna, Austria). A random effects model was applied to calculate RR, and 95% confidence intervals (CI) were determined using the Mantel-Haenszel method. For the quantification of heterogeneity, values of I 2 and tau-squared (T 2 ) were assessed based on the DerSimonian-Laird estimation. Visual confirmation of publication bias was analyzed by using funnel plots with a diagonal 95% CI line and standard error axis, and the significance threshold of Egger's regression test was set at P = .05.
RESULTS
The flow diagram of the literature search is presented in Figure 1 . Among 391 abstracts that were screened, 51 articles were subjected to full-text review. Finally, 26 articles met the eligibility criteria for inclusion in the systematic review. 6, Four articles 31, 32, 44, 45 had the same database (National Surgical Quality Improvement Program, NSQIP), as well as similar study size, subgroup analysis, and statistical analysis. In the meta-analysis of patients with BMI > 30 kg/m 2 and complication risk, the study by Nelson et al 31 included the largest study population, and for analysis of the tissue necrosis rate, data were extracted from the study by Gust et al, 32 which reported tissue necrosis incidence.
Systematic Review
Among the 26 studies, 22 were retrospective reviews. Two studies used surgeon-reported data (NSQIP), and two studies were conducted using insurance databases (Blue Cross Blue Shield 43 and Cosmetassure 20 ). Four studies were prospective, 26, 39, 41 including one randomized controlled trial. 30 The remaining 18 studies were reviews of institutional medical records.
A total of 15 studies, including two studies with a duplicated patient pool, reported that a high BMI or body weight significantly increased the risk of perioperative surgical complications (Table 1 ). In contrast, 11 studies showed no direct evidence or a statistically significant relationship between high BMI and the complication rate (Table 2 ). Three articles investigated the "cutoff point" of BMI (the point at which the risk of complications rapidly increases). Manahan et al 29 
Meta-Analysis
Based on the NOS star assessment, 12 articles were rated as high quality, with six or more stars. Seven articles received eight or more points, and two articles received six points. 38, 39 
Obesity (BMI > 30 kg/m 2 ) and Complication Risk
Among the articles selected for meta-analysis based on the previously mentioned criteria (Figure 2) , the study by Chen et al 43 was excluded, because although the paper defined obesity as BMI > 30 kg/m 2 or "as a diagnosis from chart review," an overwhelming majority of cases were diagnosed using the latter method, and no additional exact standards were available. A total of 12 studies that included 6904 patients who underwent reduction mammaplasty (3752 obese and 3152 non-obese), were included in the meta-analysis.
The pooled RR of surgical complications was higher in obese patients than in non-obese patients (RR = 1.45, 95% CI 1.21-1.75, range 1.02-3.00, I 2 = 57%, T 2 = 0.0443). The funnel plot (Figure 3 Among surgical complications, necrosis of the skin, including the nipple, and fat was a relatively severe occurrence involving a high risk of reoperation or revision. Subgroup analysis was conducted using studies that reported the incidence of tissue necrosis ( Figure 5 ). The pooled RR of necrosis was higher than that of surgical complications in obese (BMI > 30 kg/m 2 ) patients (RR = 2.01, 95% CI 1.54-2.63, I 2 = 1.3%, T 2 = 0.0017).
DISCUSSION
Macromastia or gigantomastia in women is considered a condition that impairs body function and causes painful symptoms rather than a condition that purely causes cos- metic dissatisfaction. Hence, reduction mammaplasty is generally considered a curative surgery rather than an aesthetic surgery, and this trend has been supported by numerous outcome studies, 4,46-49 as healthcare payers and medical insurance authorities have been encouraged to broaden their coverage of reduction mammaplasty. 27, 50 Furthermore, surgical indications and patient selection issues in reduction mammaplasty have been debated, including evaluation of various predisposing factors and risk analyses.
Complication rate analyses of obese patients undergoing reduction mammaplasty have been performed to determine the risks and benefits of the procedure. Compared to well-known risk factors, such as active smoking 13 and ongoing diabetes mellitus, 8, 9, 14 obesity is not definitively regarded as a factor that increases the surgical risk, as the results of previous studies have been somewhat divergent and conflicting. On reviewing the relationship between obesity and surgical complications, we felt that it was necessary to perform a meta-analysis with a larger and broader study population. Therefore, we assessed whether obesity actually increases the risk of complications after reduction mammaplasty and determined the extent of this risk. There have been very few reports about serious medical complications, including pulmonary and cardiac events, thromboembolism, and death, after reduction mammaplasty, and thus, in the present study, we analyzed the incidence of only surgical complications, namely local surgical site infection, delayed wound healing, wound dehiscence, hematoma, seroma, and tissue necrosis.
To date, there have been conflicting opinions as to whether obesity is associated with the complication rate, and the risk might be over twofold higher in obese patients than in non-obese patients. In the present study, the overall complication rate of obese patients (BMI > 30 kg/m 2 ) was higher than that of non-obese patients, with a pooled risk of 1.45 (95% CI 1.21-1.75). As high BMI is strongly related to the presence of metabolic disorders, such as diabetes and a high lipid profile, these results are not surprising. When considering breast reduction in obese patients, clinicians should be particularly attentive to preoperative patient education, surgical planning, and postoperative management.
In the present study, the pooled risk of skin and fat necrosis was 2.01 (95% CI 1.54-2.63) in the obese group (compared with the non-obese group). Tissue necrosis complications are relatively difficult to manage and frequently require additional revision, leading to an increase in the risk of additional procedures and poor patient satisfaction. Based on the results, surgeons should be aware that when performing reductions in obese patients, relatively conservative surgical planning, avoidance of massive tissue removal, and low volume reduction could lead to positive outcomes with regard to postoperative results and general patient satisfaction.
It is somewhat inappropriate to generalize that high BMI should be considered an exclusion criterion of reduction mammaplasty. According to a similarly designed meta-analysis by Kerkoffs et al in 2012, 51 the pooled odds ratios of infection and deep infection during total knee arthroplasty were 1.90 and 2.38, respectively, in obese patients with BMI > 30 kg/m 2 . In a 2014 meta-analysis by Lee and Mun 52 regarding obesity and the pooled complication risk of breast reconstruction, obese patients with BMI > 30 kg/m 2 had significantly increased risks of total flap loss (RR = 1.68) and overall abdominal complications (RR = 1.53). In 2009, Momeni et al 53 presented a study on abdominoplasty, which is a cosmetic surgical operation performed in a similar proportion of obese patients as reduction mammaplasty, and the authors reported that the risk of major complications with this procedure was over two-fold higher in obese patients than in non-obese patients (20.8% vs 9.7%). Reduction mammaplasty does not specifically carry a high risk for obese patients, and therefore, there is no reason to exclude obese patients from undergoing the procedure or to postpone reduction mammaplasty until the patient has successfully lost weight. This surgery has been shown to have a positive effect on additional weight reduction in obese patients, 54, 55 as it relieves their functional impairment and encourages more physical activity and high self-confidence. Nevertheless, neglecting the risks of high baseline body weight can interfere with a surgeon's ability to assess operational risk and provide accurate information to the patient. Patients with severe, morbid obesity may be more susceptible to surgical complications and discomfort, as the pooled risks of patients with BMI > 35 kg/m 2 (class II) and those with BMI > 40 kg/m 2 (class III) gradually increased (1.71 and 2.05, respectively) compared to that of patients with BMI > 30 kg/m 2 . Extensive surgical planning for reducing additional breast tissue should be avoided, especially in morbidly obese patients, and patients should be encouraged to attempt preoperative weight reduction. 28, 30, 56 The present study has several limitations. First, this meta-analysis was based on observational studies, and therefore, there was a high risk of selection and publication bias. The calculation of RR would have been more meaningful if the meta-analysis included studies with a randomized control design and a prospective cohort. Second, potential confounders were not considered. Study screening and exclusion of other potential confounders was not possible owing to the nature of a meta-analysis. The major potential confounders, according to previous publications, are active smoking and resection weight or volume of the operated breast. However, as mentioned earlier, active smoking has been shown to negatively impact surgical outcomes in both in vivo and experimental studies, and since resection weight is relatively proportional to a patient's body weight, 56 these variables unlikely influenced the outcome of the present study. Third, the study did not assess the risks of specific complication types or surgical methods. While analyzing the rate of complications, rather than analyzing the incidences of specific complication types, such as infection, hematoma, seroma, and wound dehiscence, the data were grouped. Moreover, there are many surgical options, including liposuction, round-type incision, vertical reduction, and inverted T resection; however, the results of these different procedures could not be reviewed owing to an insufficient number of reports. Data heterogeneity in the meta-analysis is likely due to subtle differences in the reporting pattern; the range of complications, symptoms, and follow-up periods; and the limitation of pooled data. Nevertheless, to our knowledge, this study is the first meta-analysis and systematic review to assess the surgical risk of obesity in reduction mammaplasty, and as such, it provides objective conclusions on this controversial topic.
CONCLUSION
The surgical risk of obesity is a controversial topic and is especially important in reduction mammaplasty, as most patients who require this surgery are relatively overweight. The risk of surgical complications and tissue necrosis after reduction mammaplasty is high in obese patients and gradually increases with an increase in the severity of obesity; however, the risk is not extremely high when compared to the risk for other types of surgeries. Based on the findings, we believe that every surgeon should consider the risks and benefits of reduction mammaplasty carefully during patient selection and should appropriately plan the surgery.
